Anaptysbio (ANAB) Receivables - Net (2016 - 2025)
Anaptysbio's Receivables - Net history spans 9 years, with the latest figure at $33.8 million for Q4 2025.
- For Q4 2025, Receivables - Net fell 16.96% year-over-year to $33.8 million; the TTM value through Dec 2025 reached $33.8 million, down 16.96%, while the annual FY2025 figure was $33.8 million, 16.96% down from the prior year.
- Receivables - Net reached $33.8 million in Q4 2025 per ANAB's latest filing, down from $75.7 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $75.7 million in Q3 2025 to a low of $642000.0 in Q2 2021.
- Average Receivables - Net over 5 years is $12.0 million, with a median of $3.2 million recorded in 2023.
- Peak YoY movement for Receivables - Net: tumbled 75.06% in 2021, then surged 520.62% in 2025.
- A 5-year view of Receivables - Net shows it stood at $876000.0 in 2021, then soared by 61.99% to $1.4 million in 2022, then surged by 382.8% to $6.9 million in 2023, then surged by 495.02% to $40.8 million in 2024, then decreased by 16.96% to $33.8 million in 2025.
- Per Business Quant, the three most recent readings for ANAB's Receivables - Net are $33.8 million (Q4 2025), $75.7 million (Q3 2025), and $21.4 million (Q2 2025).